[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-326806-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-326806-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","revolutionizing-cancer-care-strategies-immunotherapy-gene-therapy-and-molecular-targeted-therapy-review-article","Revolutionizing cancer care strategies - immunotherapy, gene therapy, and molecular targeted therapy - review article","","Despite technological progress in conventional anti-cancer therapies, safer and more precisely targeted treatment strategies remain urgently needed. Conventional approaches often suffer from systematic toxicity, reduced quality of life, and severe side effects that limit clinical effectiveness. Advances in cancer biology are accelerating innovative and safer options including immunotherapy, gene therapy, and molecular targeted therapy. This review analyzes the achievements and challenges of these advanced modalities and outlines future perspectives based on molecular mechanisms of carcinogenesis and disease prognosis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/healthcare/","Healthcare",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/revolutionizing-cancer-care-strategies-immunotherapy-gene-therapy-and-molecular-targeted-therapy-review-article/326806/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/revolutionizing-cancer-care-strategies-immunotherapy-gene-therapy-and-molecular-targeted-therapy-review-article/326806.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are more precise cancer treatment strategies needed beyond conventional anti-cancer therapies?","Question",{"text":63,"@type":64},"Conventional therapies are limited by systematic toxicity, compromised quality of life, and severe side effects. The document argues that safer, personalized, and more effective strategies are urgently required.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does immunotherapy aim to target cancer cells?",{"text":68,"@type":64},"Immunotherapy is based on directing the immune response specifically toward cancerous cells, often with fewer off-target effects compared with chemotherapy. It includes strategies to activate or boost immune responses against cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"What historical developments shaped immunostimulant-based immunotherapy?",{"text":72,"@type":64},"Coley observed sarcoma reduction after injecting gram-positive bacteria, leading to Coley toxin as an early immunostimulant. Later milestones include Bacillus Calmette–Guerin approval for some malignancies and evidence for interferon-α and interleukin-2 in various cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},326806,1790439791,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":108,"slug":109},7,40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":111,"show_sort_weight":112,"slug":113},"Research & Report",30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":107,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","Molecular Biology Reports (2024) 51:219  \n[https://doi.org/10.1007/s1](https://doi.org/10.1007/s1) 1033-023-09096-8  \nRevolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy  \nAasma Zafar1 · Muhammad Jawad Khan1 · Junaid Abu2 · Aisha Naeem3  \nReceived: 18 August 2023 / Accepted: 4 December 2023 / Published online: 28 January 2024 © The Author(s) 2024  \nAbstract  \nDespite the availability of technological advances in traditional anti-cancer therapies, there is a need for more precise and targeted cancer treatment strategies. The wide-ranging shortfalls of conventional anticancer therapies such as systematic toxicity, compromised life quality, and limited to severe side effects are major areas of concern of conventional cancer treatment approaches. Owing to the expansion of knowledge and technological advancements in the field of cancer biology, more innovative and safe anti-cancerous approaches such as immune therapy, gene therapy and targeted therapy are rapidly evolving with the aim to address the limitations of conventional therapies. The concept of immunotherapy began with the capability of coley toxins to stimulate toll-like receptors of immune cells to provoke an immune response against cancers. With an in-depth understating of the molecular mechanisms of carcinogenesis and their relationship to disease prognosis, molecular targeted therapy approaches, that inhibit or stimulate specific cancer-promoting or cancer-inhibitory molecules respectively, have offered promising outcomes. In this review, we evaluate the achievement and challenges of these technically advanced therapies with the aim of presenting the overall progress and perspective of each approach.  \nKeywords Immunotherapy · Gene therapy · Targeted molecular therapy  \nIntroduction  \nCells acquire a cancerous phenotype due to a multitude of aberrant changes that manifest at the levels of proteins, RNA, or DNA. The year 2020 witnessed staggering statistics from the World Health Organization (WHO)—one-sixth of global deaths were attributed to cancer, underscoring the urgent necessity for safer, personalized, and more effective  \n* Aisha Naeem  \n[an594@georgetown.edu](an594@georgetown.edu); [a.naeem@qu.edu.qa](a.naeem@qu.edu.qa)  \nAasma Zafar  \n[aasmazafar584@gmail.com](aasmazafar584@gmail.com)  \nMuhammad Jawad Khan  \n[jawadkhan@comsats.edu.pk](jawadkhan@comsats.edu.pk)  \nJunaid Abu  \n[jabu@hamad.qa](jabu@hamad.qa)  \n1 Department of Biosciences, COMSATS University, Islamabad 45550, Pakistan  \n2 Hazm Mebaireek General Hospital, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar  \n3 Qatar University Health, Qatar University, P.O. Box 2713, Doha, Qatar  \ntreatment modalities. While conventional anticancer methods such as surgery, radiotherapy, and hormonal therapy [1] have shown advancements, the realm of cancer therapeuticsis abuzz with exploration aimed at enhancing survival rates. Within this landscape, emerging treatment avenues including immunotherapy, gene therapy, and molecular targeted therapy are offering promising prospects. These innovative therapeutic paradigms have historical roots, but it’s the availability of comprehensive genomic and individualized data that has truly refined their applications. The core objective of these groundbreaking treatments is to overcome the limitations inherent in traditional anticancer approaches—adverse treatment effects and long-term side effects.  \nIn spite of these strides, cancer stands as the second leading cause of mortality, prompting an urgent quest for precise, targeted anticancer interventions to improve tolerance and mitigate both immediate and enduring side effects. The pursuit of better outcomes steers oncologists towards a strategy of integrated disease management, entailing dynamic treatment regimens that optimize cancer management. This article delves into anti-cancer therapeutic methods—immunotherapy, gene therapy, and molecular targeted therapy—tracing their his","cbCaitbhgcpoikYV","https://ap.wps.com/l/cbCaitbhgcpoikYV","pdf",1355605,14,"English","# Introduction\n## Immunotherapy\n### Immunostimulant","[{\"question\":\"Why are more precise cancer treatment strategies needed beyond conventional anti-cancer therapies?\",\"answer\":\"Conventional therapies are limited by systematic toxicity, compromised quality of life, and severe side effects. The document argues that safer, personalized, and more effective strategies are urgently required.\"},{\"question\":\"How does immunotherapy aim to target cancer cells?\",\"answer\":\"Immunotherapy is based on directing the immune response specifically toward cancerous cells, often with fewer off-target effects compared with chemotherapy. It includes strategies to activate or boost immune responses against cancers.\"},{\"question\":\"What historical developments shaped immunostimulant-based immunotherapy?\",\"answer\":\"Coley observed sarcoma reduction after injecting gram-positive bacteria, leading to Coley toxin as an early immunostimulant. Later milestones include Bacillus Calmette–Guerin approval for some malignancies and evidence for interferon-α and interleukin-2 in various cancers.\"}]","Revolutionizing cancer care strategies - immunotherapy, gene therapy, and molecular targeted therapy - review article | PDF",1789975404,35]